Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

PHASE2TerminatedINTERVENTIONAL
Enrollment

624

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Fostamatinib Disodium (R935788)

50 mg PO BID; 100 mg PO BID; 100 mg PO QD; 150 mg tablet PO QD

Trial Locations (76)

Unknown

Research Site, La Jolla

Research Site, Palm Desert

Research Site, Palo Alto

Research Site, San Diego

Research Site, Santa Maria

Research Site, Hamden

Research Site, Washington D.C.

Research Site, Aventura

Research Site, Boca Raton

Research Site, Gainesville

Research Site, Ocala

Research Site, Orange Park

Research Site, Orlando

Research Site, South Miami

Research Site, Venice

Research Site, Boise

Research Site, Coeur d'Alene

Research Site, South Bend

Research Site, Elizabethtown

Research Site, Cumberland

Research Site, Hagerstown

Research Site, Lansing

Research Site, Omaha

Research Site, Roslyn

Research Site, Smithtown

Research Site, Raleigh

Research Site, Mayfiled Village

Research Site, Erie

Research Site, Willow Grove

Research Site, Wyomissing

Research Site, Jackson

Research Site, Austin

Research Site, San Antonio

Research Site, Oklahoma City

Research Site, Spokane

Research Site, Antwerp

Research Site, Ghent

Research Site, Liège

Research Site, Plovdiv

Research Site, Rousse

Research Site, Sofia

Research Site, Barranquilla

Research Site, Bogotá

Research Site, Bucaramanga

Research Site, Medellín

Research Site, Bordeaux

Research Site, Hamburg

Research Site, Leipzig

Research Site, Würzburg

Research Site, Siena

Research Site, Udine

Research Site, Chihuahua City

Research Site, Cuernava

Research Site, Del. Cuauhtemoc

Research Site, Guadalajara

Research Site, León

Research Site, Mexcio

Research Site, México

Research Site, Morelia

Research Site, San Luis Potosí City

Research Site, Jesus Maria

Research Site, Lima

Research Site, Bialystok

Research Site, Bytom

Research Site, Elblag

Research Site, Grodzisk Mazowiecki

Research Site, Krakow

Research Site, Lublin

Research Site, Torun

Research Site, Wroclaw

Research Site, Zyrardów

Research Site, Brailari

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Sf. Gheorghe

Research Site, Sibiu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY